Zynerba Pharmaceuticals Inc. is a biopharmaceutical company that specializes in the development of innovative cannabinoid treatments. Their goal is to provide solutions for patients suffering from a variety of disorders, including epilepsy and Fragile X syndrome. With a focus on precision medicine, Zynerba is committed to improving the lives of patients worldwide.